Morocco announced plans to locally produce Sinopharm COVID-19 vaccine
Morocco on Monday announced plans to locally produce Sinopharm COVID-19 vaccine, adding that five million Sinopharm COVID-19 vaccine doses could soon be produced per month.
Citing a report from state news agency MAP, Reuters reported that Moroccan pharmaceutical firm Sothema (Société Thérapeutique Marocaine) will soon start production of five million Sinopharm COVID-19 vaccine doses per month in the North African country.
The said announcement was made at a ceremony chaired by King Mohammed VI during which the Moroccan government, Sothema, and Sinopharm also signed deals to produce the COVID-19 vaccine in Morocco, which had a population of about 36 million.
Based on a report on MAP, the said project will involve an investment of around USD 500 million. However, the said report didn’t say when production will start.
READ ALSO: FDA OKs Sinopharm COVID-19 Vaccine For Emergency Use In PH
The Moroccan government also signed an agreement with Sweden’s Recipharm to set up a plant in Morocco in order to produce other key vaccines.
Morocco, which rolled out a COVID-19 vaccination campaign last January, had vaccinated more people against the coronavirus disease than other African countries as it had administered 19.23 million doses of AstraZeneca and Sinopharm COVID-19 vaccines as of July 5, 2021.
The country had received 20.4 million COVID-19 vaccine doses so far and planned to vaccinate everyone over the age of 17. Morocco had registered 534,550 coronavirus infections and 9,319 deaths due to COVID-19.
What can you say about this? Let us know in the comments below.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
